Why Is THERMO FISHER SCIENT (TMO) Stock Moving Today?

Thermo Fisher Scientific (TMO) surged 8.71% to $572.32 in a session marked by strong earnings and revised guidance. The stock climbed following the release of better-than-expected second-quarter results and an upward revision of full-year 2026 guidance. Management highlighted stronger customer activity, particularly in the pharmaceutical and biotechnology sectors, as a key driver of performance.

What Happened

Thermo Fisher Scientific reported Q2 2026 results that exceeded expectations, with organic revenue growth of 5%. The company raised its full-year 2026 revenue guidance to a range of $47.4 billion to $48.1 billion and adjusted EPS guidance to $24.93 to $25.33. These updates reflect improved end-market activity and margin expansion. The microbiology division's divestiture also contributed to a cleaner financial picture, while the company continued its buyback program and launched new AI-powered products. The improved outlook and strong performance led to a sharp rise in the stock price.

What The Data Shows

TMO's fundamentals reflect a strong market position with a market cap of $195.6 billion, a P/E ratio of 31.5, and trailing 12-month revenue growth of 5.4%. The company's net margin stands at 15.2%, and its beta of 0.87 suggests lower volatility than the broader market. The stock opened at $566.61, a 1.0% gap down from the prior close, but the session saw no intraday movement beyond the opening price. Volume has been negligible so far, at 0.0 million shares traded. The stock is currently within its 52-week range of $435.27 to $643.99, having printed one fresh 52-week high on July 24.

What To Watch

The company is scheduled to provide updated 2025 guidance in its Q3 2025 earnings report, which will be a key event for investors. Coverage breadth is also worth monitoring, as 14 stories from 10 sources have been published in the last 36 hours.